PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Similar documents
Formulation and Evaluation

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL

Formulation and evaluation of immediate release salbutamol sulphate

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

Formulation and evaluation of fast dissolving tablet of aceclofenac

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting

Research Journal of Pharmaceutical, Biological and Chemical Sciences

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Available Online through

Received on: Accepted on:

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

Formulation and evaluation of sublingual tablets of lisinopril

Optimization of valsartan tablet formulation by 2 3 factorial design

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Formulation and Evaluation of Orally Disintegrating Tablets of Buspirone

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Formulation and Optimization of Lamotrigin Fast Dissolving Tablet

Ajmer , India. * Correspondence rediffmail.com, Ph :

International Journal of Innovative Pharmaceutical Sciences and Research

Formulation and evaluation of oro-dispersible tablets of lafutidine

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

FAST DISPERSING TABLETS REVIEW Chetan V. Suryawanshi*, N. A. Gujrathi, B. R. Rane

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

Received on: Accepted on:

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Formulation Design and Optimization of Fast Disintegrating Lorazepam Tablets by Effervescent Method

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

Design and development of fast Melting Tablets of Terbutaline Sulphate

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

International Journal of Pharmacology and Pharmaceutical Sciences 2016; Vol: 3, Issue: 3, 14-18

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF ORODISPERSIBLE TABLETS OF CETIRIZINE HYDROCHLORIDE

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Formulation and Development of Olanzapine Orally Disintegrating Tablets

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

International Journal of Pharma and Bio Sciences NOVEL CO-PROCESSED SUPERDISINTEGRANTS IN THE DESIGN OF FAST DISSOLVING TABLETS

Available online through ISSN

Formulation and development of orodispersible tablet of Memantine HCl by sublimation approach

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Int. J. Pharm. Sci. Rev. Res., 33(1), July August 2015; Article No. 12, Pages: 55-61

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

Optimisation of Orodispersible Tablet of Amlodepine, Ramipril in Fixed Dose Combination by Using Quality by Design (QbD) Approach

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE

DESIGN AND EVALUATION OF COST EFFECTIVE ORODISPERSIBLE TABLETS OF DIETHYLCARBAMAZINE CITRATE BY EFFERVESCENT METHOD

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

Available Online through Research Article

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Available online Research Article

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

D.G.Umalkar et al, /J. Pharm. Sci. & Res. Vol.2 (8), 2010,

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Research Article. Formulation and in-vitro evaluation of levocetirizine dihydrochloride orodispersible tablets

M.Vijaya Laxmi et al., Asian Journal of Pharmaceutical Technology & Innovation, 03 (10); 2015; Research Article

Research Article Formulation and Evaluation of Dual Component Tablets of Metoprolol tartrate

Available online through

Formulation Development and Evaluation of Antidiabetic Polyherbal Tablet

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

FORMULATION AND EVALUATION OF AMISULPRIDE ORODISPERSIBLE TABLET

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

Formulation Development and Evaluation of Modified Release Tablet using a Fixed Dose Combination of Antidiabetic Agents

Formulation and evaluation of oral dispersible tablets of aripiprazole

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

Scholars Research Library. Formulation and evaluation of rizatriptan benzoate orodispersible tablets

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

Formulation Development and Evaluation of Ondansetron Hcl Fast Dispersing Tablets for Treatment of Chemotherapy

Formulation and Evaluation of Fast Disintegrating Tablets of Caffeine by Using Effervescent Formulation Approach

FORMULATION AND EVALUATION OF SUBLINGUAL TABLET FOR NARATRIPTA

Biswajit Biswal IRJP 2 (7)

Vol - 4, Issue - 2, Apr 2013 ISSN: Trambadiya et al PHARMA SCIENCE MONITOR

Transcription:

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES FORMULATION AND OPTIMIZATION OF FAST DISINTEGRATING TABLET OF METFORMIN USING DISINTEGRANT BLENDS FOR IMPROVED EFFICACY N. R.Maniyar 1*, K. M. Ranch 2, A. R. Koli 2, B. A.Vyas 2, R. K. Parikh 3, J.G. Modi 1, R. B.Vyas 2. 1 Department of Quality Assurance, Vidhyabharti Trust College of Pharmacy, Umrakh 394 345, Gujarat, India. 2 Maliba Pharmacy College, Bardoli 394 350, Gujarat, India. 3 L.M. College of Pharmacy, Ahmedabad, Gujarat, India. ABSTRACT Metformin hydrochloride is an orally administered antihyperglycemic agent, used in the management of non-insulin dependent (type-2) diabetes mellitus. Difficulty in swallowing (dysphagia) is common among all age groups, especially in elderly and pediatrics. Unfortunately, a high percentage of patients suffering from type-2 diabetes are elderly people showing dysphagia. In the present work, fast Disintegrating tablets of Metformin were designed with a view to enhance patient compliance. In this study, fast disintegrating tablets were prepared using direct compression method. The tablets of metformin were prepared using combination of superdisintegrants; sodium starch glycollate and Kyron T-314. The presence of highly porous structure in tablet matrix is the key factor for rapid disintegration of fast disintegrating tablet. To improve porosity, volatile substance camphor was also used in tableting process, which sublimated from the formed tablet. The strong saline and slight bitter taste of the drug was masked using sweetener mannitol which also enhanced the mouth feel of tablet. The tablets were evaluated for percentage friability, wetting time, and disintegration time. In the investigation, a 2 3 full factorial design was used to investigate the joint influence of three formulation variables: amount of camphor, sodium starch glycollate and Kyron T-314. The results of analysis revealed that for obtaining a rapidly disintegrating dosage form, tablets should be prepared using an optimum concentration of camphor and a lower percentage of each sodium starch glycollate and Kyron-T 314. The systematic formulation approach helped in understanding the effect of formulation processing variables. Keywords: Fast Disintegrating Tablet, 2 3 Full Factorial Design, Metformin hydrochloride, Kyron T-314, Camphor www.pharmasm.com 1

INTRODUCTION Convenience of administration and patient compliance are gaining significant importance in the design of dosage forms. Recently more stress is laid down on the development of organoleptically elegant and patient friendly drug delivery system for pediatric and geriatric patients. [1,2] Many patients, elderly people and person with dysphagia find it difficult to swallow the tablets and hard gelatine capsules and thus do not comply with prescription, which results in high incidence of noncompliance and ineffective therapy. Unfortunately, a high percentage of patients suffering from type-2 diabetes are elderly people showing dysphagia. The above problem becomes even more severe due to big tablets (high dose 500-1000 mg) and need for daily intake of the drug. A tablet comprising 1000 mg of metformin hydrochloride would need to have a size of 19 mm 10.5 mm (Glucophage 1000 mg tablets) or more as functional excipients are needed to modify release of drug from the dosage form and would be very difficult to swallow. [3,4] Fast dissolving tablets disintegrate or dissolve in saliva and are swallowed without water. The main purpose of this work is only to improve patient compliance without compromising the therapeutic efficacy. The objective of this study was also to investigate the combined effect of the disintegrants, subliming agent on the properties of fast dissolving tablet of Metformin HCl. MATERIALS AND METHODS MATERIALS Metformin HCl was obtained from Yarrow chem (Mumbai); Kyron T-314 was obtained as gift sample from Corel Pharmaceutical, Ahmedabad. Croscarmellose was gifted from Zydus Cadila Health care Ltd. (Ahmedabad). Sodium starch glycolate (SSG), camphor, menthol, thymol, magnesium stearate, talc, microcrystalline cellulose and mannitol were purchased from Shraddha chemicals (Vadodara). METHODS Preparation of Tablets Metformin HCl tablets each containing 250 mg drug was prepared by the direct compression method. In direct compression method all the ingredients were passed through # 60 sieve. Metformin HCl, mannitol, Camphor were triturated in a glass mortar. Microcrystalline cellulose, Kyron T-314 and sodium starch glycolate were incorporated www.pharmasm.com 2

in the powder mixture and finally magnesium stearate and talc were added as lubricant. The powder mixture was weighed and compressed with 10 mm flat face surface punches. After compression the tablets were collected and vacuum dried at 60 C for 24 hours to facilitate sublimation of camphor. The composition of various tablet batches and the factorial design batches are as shown in Table I & II respectively. TABLE I: TABLET FORMULATION Formulation Ingredients (mg) F 1 F 2 F 3 F 4 F 5 F 6 F 7 F 8 Metformin HCl 250 250 250 250 250 250 250 250 Kyron T-314 4 8 4 8 4 8 4 8 Camphor 45 45 80 80 45 45 80 80 Sodium starch glycolate 17.5 17.5 17.5 17.5 32.5 32.5 32.5 32.5 Mannitol 75 75 75 75 75 75 75 75 Talc 3 3 3 3 3 3 3 3 Magnesium stearate 6 6 6 6 6 6 6 6 Microcrystalline cellulose (q.s to) 500 500 500 500 500 500 500 500 TABLE II: 2 3 FULL FACTORIAL DESIGN LAYOUT Batch code X 1 (mg) X 2 (mg) X 3 (mg) DT ± SD (Sec) % F ± SD F 1-1 -1-1 77± 2.86 0.58 ± 0.034 F 2 1-1 -1 43± 2.12 0.61± 0.061 F 3-1 1-1 60±1.92 0.89± 0.041 F 4 1 1-1 34± 1.3 0.85± 0.059 F 5-1 -1 1 54 ±1.58 0.55± 0.043 F 6 1-1 1 29± 1 0.57± 0.067 F 7-1 1 1 40 ± 1.78 0.88± 0.062 F 8 1 1 1 24 ± 2.07 0.89± 0.029 Check Point -0.1 0 0.9 36±1.5 0.62±0.06 www.pharmasm.com 3

Evaluation of Tablet Properties Hardness determination: The crushing strength of the tablets was measured using a Monsanto hardness tester. Friability: The friability of a sample of 20 tablets was measured using a Roche Friabilator (Electrolab). Twenty preweighed tablets were subjected to combined effect of shock and abrasions in a plastic chamber revolving at 25 rpm for 4 minutes. The tablets were then reweighed after removal of fines (using no. 60 mesh screen), and the percentage of weight loss was calculated [5]. Disintegration time: The time required for disintegration of six tablets, placed in each tube of disintegration test apparatus, was measured at 37±2 C using 900 ml distilled water. The time for the tablet to completely disintegrate into fine particles was noted [5]. Wetting time: The wetting time of the tablets was measured using a simple procedure. Five circular tissue papers of 10-cm diameter were placed in a petri dish of 10-cm diameter. Ten milliliters of water containing eosin, a water-soluble dye, was added to the petri dish. A tablet was carefully placed on the surface of tissue paper. The time required for water to reach the upper surface of the tablets was noted as the wetting time [6]. Full Factorial Design The factorial design is a technique that allows identification of factors involved in a process and assesses their relative importance. In addition, any interaction between factors chosen can be identified. Construction of a factorial design involves the selection of parameters and the choice of responses. In this study, a 2 3 factorial plan was used to determine the effects of formulation variables. In this design three factors are evaluated, each at two levels, and experimental trials are performed at all eight possible combinations [7,8]. The amount of subliming agent, amount of Kyron T-314 (X 1 ), amount of camphor (X 2 ) and amount of sodium starch glycollate (X 3 ) was selected as independent variables. The disintegration time and percentage friability were selected as dependent variables. The three factors and their levels are shown in Table III. The levels for each factor are represented by a (-) sign for the low level and a (+) for the high level. The matrix of the factorial design is depicted in Table IV. www.pharmasm.com 4

TABLE III: THREE FACTORS AND THEIR LEVELS Coded Values Actual Values X 1 (mg) X 2 (mg) X 3 (mg) -1 4 45 17.5 1 8 80 32.5 X 1 : Amount of Kyron T-314, X 2 : Amount of Camphor, X 3 : Amount of Sodium starch glycolate TABLE IV: THE MATRIX OF THE FACTORIAL DESIGN Batch code X 1 X 2 X 3 X 1 X 2 X 1 X 3 X 2 X 3 X 1 X 2 X 3 F 1 - - - + + + - F 2 + - - - - + + F 3 - + - - + - + F 4 + + - + - - - F 5 - - + + - - + F 6 + - + - + - - F 7 - + + - - + -+ F 8 + + + + + + + RESULT AND DISCUSSION On the basis of the results obtained in the preliminary screening studies, the batch containing Kyron T-314 showed the fastest disintegration and sodium starch glycollate is widely used in industry, hence, these superdisintegrants were selected for studies. The crushing strength of the tablets was adjusted to 4 kilopond (kp). Subliming agents such as menthol, camphor, and thymol were used to increase porosity of the tablets in the preliminary tablet formulations. Camphor-containing tablets exhibited faster disintegration as compared with tablets containing menthol and thymol. Hence, it was www.pharmasm.com 5

selected further studies. The tablet formulation for preliminary batches and results of preliminary studies are shown in the Table V and VI respectively. The porous structure is responsible for faster water uptake; hence it facilitates wicking action of superdisintegrant in bringing about faster disintegration. TABLE V: TABLET FORMULATION FOR PRELIMINARY BATCHES Formulation Ingredients (mg) A 1 A 2 A 3 C 1 C 2 C 3 Metformin HCl 250 250 250 250 250 250 Kyron T-314 6 - - - - - Sodium starch glycolate - 6 - - - - Cross carmalose - - 6 - - - Camphor - - - 45 - - Thymol - - - - 45 - Menthol - - - - - 45 Mannitol 75 75 75 75 75 75 Talc 3 3 3 3 3 3 Magnesium stearate 6 6 6 6 6 6 Microcrystalline cellulose (q.s. to) 500 500 500 500 500 500 TABLE VI: RESULTS OF PRELIMINARY SCREENING STUDIES Batch DT ± SD (Seconds) % F ± SD A 1 42 ± 1.87 0.41 ± 0.012 A 2 76 ± 1.14 0.26 ± 0.013 A 3 65 ± 1.14 0.31 ± 0.014 C 1 68 ± 1.92 0.45 ± 0.015 C 2 83 ± 1.48 0.3 ± 0.017 C 3 76 ± 1.58 0.25 ± 0.013 The use of a sublimation agent resulted in increased friability probably due to increased porosity. The results shown in Table II reveal that sublimation of camphor from www.pharmasm.com 6

tablets resulted in faster disintegration. The compaction process might have caused breakage of porous packing and subsequent reduction in porosity. The tablets required about 20 hours of drying. In order to investigate the factors systematically, a factorial design was employed in the present investigation. Optimization procedure is facilitated by the fitting of an empirical polynomial equation to the experimental results. The results were analyzed with multiple regression analysis using ReliaSoft DOE++. Factorial design The amount of superdisintegrant (Kyron T-314, X 1 ) subliming agent (camphor, X 2 ), and sodium starch glycollate (X 3 ) were chosen as independent factors. The polynomial equations obtained correlate the factors X 1, X 2 and X 3 and their interactions with the disintegration time and %friability (Y). [9] Y = b 0 + b 1 x 1 + b 2 x 2 + b 3 x 3 + b 4 x 1 x 2 + b 5 x 1 x 3 + b 6 x 2 x 3 + b 7 x 1 x 2 x 3. where Y is the measured response, Xi is the level (e.g., concentration) of the it s factor, B 1, B 2 B 3, represent coefficients computed from the responses of the formulations in the design and B 0 represents the intercept. The values of coefficients for FM & RM are as shown in the Table VII and VIII. TABLE VII: THE VALUES OF COEFFICIENTS FOR FM & RM FOR DT Factors and Coefficients for Coefficients for RM Effects of factor Interactions FM X 1-12.625-12.625-25.25 X 2-5.6252 - -11.25 X 3-8.375-8.375-16.75 X 1 X 2 2.125-4.25 X 1 X 3 2.375-4.75 X 2 X 3 0.875-1.75 X 1 X 2 X 3 0.125-0.25 *FM indicates Full Model; and RM, Reduced Model www.pharmasm.com 7

TABLE VIII: THE VALUES OF COEFFICIENTS FOR FM & RM FOR %F Factors and Coefficients for Coefficients for Effects of factor Interactions FM RM X 1 0.0025-0.005 X 2 0.15 0.15 0.3 X 3-0.005 - -0.01 X 1 X 2-0.01 - -0.02 X 1 X 3 0.005-0.01 X 2 X 3 0.0125 0.0125 0.025 X 1 X 2 X 3 0.0075-0.015 To assess the reliability of the above-described equations, a check point batch was experimented that varied the independent variables and estimated the dependent variable. The experimental values of check point batch was compared with the predicted values gained from equations, it showed that there is good agreement between the predicted and the experimental values. The main effects of the factors on the disintegration time and % friability and their interactions were calculated using ReliaSoft DOE++. The results obtained are shown in Table VII and VIII. For the disintegration time, three factors were found to be statistically significant (P<0.05): level of Kyron T-314, SSG and the interactions between these factors were statistically significant. For % friability level of Kyron T-314 and interactions among all factors were statistically significant. It was found that an increase in the amount of any of the three independent variable causes a decrease in disintegration time. It is also evident from Table II that increase in level of camphor increases friability values of tablet. Further it is also evident from Table VII that there is no statistically significant difference in the interactions among factors for DT. It is also found that interaction among all three factors did not affect the disintegration time. The interactions of factors did not affect the friability of tablet as well. www.pharmasm.com 8

The results can also be illustrated in a main effects plot, Figure I. This graph plots the means of the high and low of each factor. From the graph, we can see that if we increase the factor A, which is the Kyron T-314 from 0.8 to 1.6 % the disintegration time will decrease. The interaction between the factors can be visualized with an interaction plot, Figure III. The interaction plot graphs the means of the replicates, organized based on the high and low of the factors. Figure II shows two lines are intersecting which indicate interaction between factor B and C. ReliaSoft DOE++ - www.reliasoft.com 60.000 disintegration time plot Main Effect dt Y' = Y A:KYRON T-314 Mean Line 52.000 44.000 D T in seconds 36.000 28.000 20.000-2.000-1.200-0.400 0.400 1.200 2.000 Factor Figure I Main effects plot ketan ranch ma liba 21-02-2009 01:44:16 Rel iasoft DOE++ - www.reli asoft.com 0.900 Interaction plot for %F Main Effect %f Y' = Y B:CAMPHOR Mean Line C:SSG Mean Li ne 0.800 0.700 % F 0.600 0.500 0.400-2.000-1.200-0.400 0.400 1.200 2.000 Factor Figure II Interaction plot for %F ketan ranch mali ba 21-02-2009 02:01:24 www.pharmasm.com 9

ReliaSoft DOE++ - www.reliasoft.com Optimal solution for %F neha paper 0.885 Factor v s Response Continuous Function Factor Value Response Value 0.820 0.755 Response %F %F (Target) Y = 0.5600 0.690 0.625 0.560 ketan ranch maliba 20-02-2009 18:00:25 45.000 52.000 59.000 66.000 73.000 80.000 17.500 20.500 23.500 26.500 29.500 32.500 B:CAMPHOR X = 45.0000 C:SSG X = 32.5000 Factors Figure III Optimization for %F CONCLUSION The results of a 2 3 full factorial design revealed that the amount of Kyron T-314, SSG and Camphor significantly affect the dependent variables, disintegration time and % friability. The amount of camphor significantly affected the percentage friability. Furthermore, the correlation between variables can be sufficiently described with polynomial equations. The validation of the equations showed that they can be used for predicting the responses. It can be also concluded that use of blend of superdisintegrants can be utilised to achieve desired responses. It is also observed that when two superdisintegrants are used along with camphor, the effect due to camphor was not statistically significant. Finally, the application of experimental design techniques, such as factorial design and optimization, was useful for identification and correlation of the significant factors that affect the properties of the ODTs. It is thus concluded that by adopting a systematic formulation approach, an optimum point can be reached in the shortest time with minimum efforts. www.pharmasm.com 10

ACKNOWLEDGEMENT The authors would like to thank Dr. D.R. Shah Principal Maliba Pharmacy College, Bardoli for providing the necessary facilities, support and help for the work undertaken. The authors also would like to thank Mr. Akshay Koli, Mr. Bhavin Vyas (MPC, Bardoli) and Mr. Milan Thakkar (NMIMS Mumbai) for providing the necessary support and help for the work undertaken. REFERENCES 1. Bhusan SY, Sambhaji SP, Anant RP, Kakasaheb RM: New drug delivery system for elderly. Indian Drugs 2000; 37:312-8. 2. Wadhwani AR, Prabhu NB, Nandkarni MA, Amin PD: Consumer friendly mucolytic formulations. Indian J Pharma Sci 2004; 7:506-7. 3. Hausler, Franz, Rohrich, Till: Effervescent Metformin composition and tablets, granules there from. 2007: WO/ 038979 A1. 4. Chandran R, Gogia A: Liquid formulation of Metformin. 2005. U.S Patent No, 6,890,957 B2. 5. Indian Pharmacopoeia 2007. Indian Ministry of Health and Family Welfare. Volume I. 183. 6. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N: Formulation Design and Optimization of Mouth Dissolve Tablets of Nimesulide using Vacuum Drying Technique. AAPS PharmaSciTech. 2004; 5 (3): 36. 7. Bolton S: Pharmaceutical Statistics. Marcel Decker Inc., Second edition 1990:234. 8. Franz RM, Browne JE, Lewis AR: Experiment design, modeling and optimization strategies for product and process development. In: Libermann HA, Reiger MM, Banker GS, eds. Pharmaceutical Dosage Forms: Disperse Systems. Marcel Dekker Inc., New York, Vol 1, 1988: 427-519. 9. Banker GS, Rhodes CT: Modern Pharmaceutics. Marcel Dekker Inc, Fourth edition 2007: 607,626. For Correspondence: Neha R. Maniyar Email: neha20985@yahoo.com www.pharmasm.com 11